Adagio Medical Holdings, Inc.
ADGM- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0002006986
No open-market purchases or sales by Adagio Medical Holdings, Inc. insiders were filed in the last 90 days; 24 institutions reported holding it in 13F filings for Q2 2026, worth $9.83M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Adagio Medical Holdings, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Adagio Medical Holdings, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Salmon Sean | Director | – | Aug 12, 2026 | 2 |
| Mirsaeedi-Farahani Keyvan | Director | – | Aug 12, 2026 | 1 |
| Cox James L | Director | 36,698 | Aug 12, 2026 | 1 |
| Gardiner Sandra A. | Director | – | Aug 12, 2026 | 1 |
| Mishan Orly | Director | – | Aug 12, 2026 | 1 |
| Moran Timothy P. | Director | – | Aug 12, 2026 | 1 |
| Usen Todd | Chief Executive Officer | 207,315 | Mar 9, 2026 | 2 |
| Kaster Deborah | Chief Financial Officer | 15,000 | Mar 9, 2026 | 2 |
| Edelman Joseph | 10% Owner | 9,675,684 | Oct 22, 2025 | 1 |
| Perceptive Advisors LLC | Director, 10% Owner | 9,675,684 | Oct 22, 2025 | 1 |
| Perceptive Life Sciences Master Fund Ltd | 10% Owner | 9,675,684 | Oct 22, 2025 | 1 |
| C2 Life Sciences LLC | Director, 10% Owner | 9,675,684 | Feb 14, 2025 | 0 |
| Stone Adam Leo | 10% Owner | 0 | Oct 1, 2024 | 0 |
| Altman Michael Seth | 10% Owner | 0 | Oct 1, 2024 | 0 |
| ARYA Sciences Holdings IV | 10% Owner | 0 | Oct 1, 2024 | 0 |
| Bergheim Olav | CEO | 22,081Indirect | Aug 2, 2024 | 0 |
| Bergheim Hakon | Chief Operating Officer | 7,539 | Aug 2, 2024 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 18, 2025 (view filing) | Dec 16 | 2 days | Kaster DeborahChief Financial Officer | PPurchase | +15.0K | $1.20 | +$18.0K | New position15.0K after | |
| Dec 15, 2025 (view filing) | Dec 12 | 3 days | Usen ToddChief Executive Officer | PPurchase | +207.3K | $1.09 | +$226.0K | New position207.3K after | |
| Oct 22, 2025 (view filing)4:33 PM ET | Oct 20 | 2 days | Perceptive Advisors LLC and 2 othersDirector, 10% Owner | PPurchaseCommon Stock or Pre-Funded Warrants | +4.03M | $0.1846 | +$744.9K | –1.34M after | Derivative3 lots |
| Oct 22, 2025 (view filing)4:33 PM ET | Oct 20 | 2 days | Perceptive Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +2.19M | $1.60 | +$3.51M | –2.19M after | Derivative |